Academic Journal
Q1Arthritis and Rheumatology
About Arthritis and Rheumatology
Arthritis and Rheumatology is a scholarly journal published by John Wiley and Sons Ltd. SCImago 2025 places it in Q1 with an SJR of 4.061 and an H-index of 373.
Its listed coverage is 2014-2026 and its research categories include Immunology (Q1); Immunology and Allergy (Q1); Rheumatology (Q1). The 2025 dataset reports 292 documents and 5781 citations across the latest three-year reporting window.
Arthritis and rheumatology are closely related fields in medicine that deal with joint disorders and autoimmune conditions. These conditions affect millions of people worldwide, causing pain, inflammation, and reduced mobility. Understanding the link between arthritis and rheumatology is essential for early diagnosis, effective treatment, and improved quality of life.
What Is Arthritis?
Arthritis is a general term used to describe over 100 different types of joint diseases. The most common forms include osteoarthritis and rheumatoid arthritis. Arthritis typically causes joint pain, stiffness, swelling, and decreased range of motion. It can affect any joint in the body but most commonly impacts the knees, hips, hands, and spine.
-
Osteoarthritis (OA) is caused by wear and tear of the cartilage, usually due to aging or injury.
-
Rheumatoid arthritis (RA) is an autoimmune disease where the body’s immune system mistakenly attacks healthy joint tissue.
Other types of arthritis include psoriatic arthritis, gout, and lupus-related arthritis.
What Is Rheumatology?
Rheumatology is a specialized branch of medicine that focuses on diagnosing and treating rheumatic diseases, including various forms of arthritis and autoimmune disorders. A rheumatologist is a medical doctor trained to treat conditions that affect the joints, muscles, and bones, as well as systemic autoimmune diseases like lupus, vasculitis, and scleroderma.
Rheumatologists use a combination of medical history, physical examination, blood tests, and imaging to diagnose these complex conditions.
Common Symptoms of Arthritis and Rheumatic Diseases
-
Persistent joint pain
-
Swelling and tenderness
-
Morning stiffness lasting longer than 30 minutes
-
Fatigue and general malaise
-
Limited movement in affected joints
-
Redness or warmth around joints
If you experience these symptoms for more than a few weeks, it’s crucial to consult a rheumatologist for proper evaluation.
Causes and Risk Factors
While the exact causes of many rheumatic diseases are still unknown, several risk factors have been identified:
-
Age: Risk increases with age, especially for osteoarthritis.
-
Genetics: Family history can influence susceptibility.
-
Gender: Women are more likely to develop autoimmune rheumatic diseases.
-
Obesity: Excess weight puts more stress on joints.
-
Infections and environmental triggers may also play a role in autoimmune reactions.
Treatment and Management
While there is no permanent cure for most types of arthritis, early diagnosis and treatment can greatly improve outcomes. Treatment options include:
-
Medications: NSAIDs, corticosteroids, DMARDs, and biologic agents.
-
Physical therapy: To improve mobility and strength.
-
Lifestyle changes: Regular exercise, a healthy diet, and weight management.
-
Surgery: Joint replacement may be recommended in severe cases.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
When it comes to managing arthritis and autoimmune conditions, expert care makes all the difference. Scope Arthritis and Rheumatology is a leading medical facility dedicated to diagnosing, treating, and managing a wide range of rheumatic diseases. With a patient-centered approach and a commitment to cutting-edge treatment, Scope provides compassionate care for those suffering from chronic joint pain, inflammation, and systemic autoimmune conditions.
What is Rheumatology?
Rheumatology is a branch of medicine that deals with the diagnosis and therapy of rheumatic diseases. These conditions often affect the joints, muscles, and bones, but can also involve internal organs. Common diseases treated by rheumatologists include:
-
Osteoarthritis
-
Rheumatoid arthritis
-
Lupus
-
Gout
-
Ankylosing spondylitis
-
Psoriatic arthritis
-
Vasculitis
-
Sjögren’s syndrome
Why Choose Scope Arthritis and Rheumatology?
1. Specialized Expertise:
Scope is home to board-certified rheumatologists with years of experience. Their deep understanding of autoimmune and musculoskeletal disorders ensures accurate diagnosis and effective treatment plans.
2. Comprehensive Services:
From early-stage arthritis to complex autoimmune conditions, Scope offers a full spectrum of diagnostic and treatment services, including blood tests, imaging, infusion therapies, joint injections, and lifestyle counseling.
3. Personalized Care Plans:
No two patients are alike. Scope’s rheumatologists develop personalized care plans tailored to each individual’s symptoms, health history, and lifestyle. The goal is to reduce pain, improve mobility, and enhance overall quality of life.
4. State-of-the-Art Technology:
The clinic uses advanced diagnostic tools and the latest treatment protocols to deliver world-class care. This includes biologic therapies, immunosuppressants, and innovative non-drug treatments.
Conditions Treated at Scope
Scope Arthritis and Rheumatology focuses on both common and rare rheumatic conditions. Some of the most frequently treated conditions include:
-
Rheumatoid Arthritis (RA): A chronic inflammatory disorder that affects joints, often leading to pain and deformity.
-
Lupus: An autoimmune disease that can impact skin, joints, kidneys, and other organs.
-
Gout: A type of arthritis caused by uric acid buildup, leading to intense joint pain.
-
Fibromyalgia: A condition marked by widespread pain and fatigue, often misunderstood or misdiagnosed.
Patient-Centered Approach
Scope emphasizes education, communication, and collaboration. Patients are encouraged to actively participate in their treatment decisions. Regular follow-ups, lifestyle guidance, and support groups are part of the holistic care model.
Convenient Access and Insurance Support
Scope accepts most major insurance plans and offers flexible appointment scheduling. Whether you're dealing with newly developed symptoms or need ongoing management for a chronic condition, Scope makes it easy to get the care you need.
Recent Research Articles
Latest publications matched automatically by ISSN.
Updated COVID ‐19 Vaccines and Health Outcomes in Patients With Autoimmune Rheumatic Conditions
Lesley E. Jackson, A. Jerrod Anzalone, Kenneth G. Saag, Rahima Begum et al.
2026-09-09 · DOI: 10.1002/art.70290Risk of Cancer According to Duration of Targeted Therapy Exposure in Spondyloarthritis: A Nationwide Cohort Study From the French Health Insurance Database
Karine Tankovic, Pascal Claudepierre, Tat Thang Vo, Tran Trong Khoi Le et al.
2026-09-08 · DOI: 10.1002/art.70297Single‐cell RNA sequencing of peripheral blood defines two immunological subtypes of Sjögren's disease distinguished by anti‐SSA antibodies and aberrant B cell populations
Geoffrey Urbanski, Kimberly E. Taylor, Emily Flynn, Armita Norouzi et al.
2026-09-07 · DOI: 10.1002/art.70320Nonmelanoma Skin Cancer Risk With JAK Inhibitors Compared to Interleukin‐6 Receptor Inhibitors in Rheumatoid Arthritis: Results From a National Cohort Study
Zixing Tian, Lianne Kearsley‐Fleet, Sizheng Steven Zhao, James Galloway et al.
2026-09-07 · DOI: 10.1002/art.70272The synergistic impact of granulocytic myeloid‐derived suppressor cells and innate lymphoid cells in systemic sclerosis
Stefanie Weber, Mario R. Angeli, Hashem Mohammadian, Hannah Labinsky et al.
2026-09-07 · DOI: 10.1002/art.70325Human Monocytic Models Reveal Genotype‐Dependent Inflammatory Programs in VEXAS Syndrome
Kana Higashitani, Tatsuma Ban, Yohei Kirino, Go R Sato et al.
2026-09-07 · DOI: 10.1002/art.70332Optimizing efficacy to safety ratio of glucocorticoids in rheumatoid arthritis models by leveraging PPARα agonism
Lisa L. Koorneef, Elisabeth Gilis, Dorien Clarisse, Daria Fijalkowska et al.
2026-09-07 · DOI: 10.1002/art.70331AMETHYST : a Retrospective Cohort Study of Treatment Patterns and Outcomes in Patients With Glucocorticoid‐refractory Macrophage Activation Syndrome Complicating Still's Disease
Alexei Grom, Jordi Antón, Edward M. Behrens, Corey Best et al.
2026-09-07 · DOI: 10.1002/art.70326String of pearls Embellishing Lupus
Sakir Ahmed, Paridhi Vaidh, Mitanjali Sethy, Pankti Ilesh Macwan et al.
2026-09-07 · DOI: 10.1002/art.70328Inhibition of Endothelial BRD4 Alleviates Lupus Nephritis partly through Interacting with FLI‐1
Xuan Wang, Xian K Zhang, Caiyun Chen, Weiru Zhang et al.
2026-09-07 · DOI: 10.1002/art.70324CD248 : Guardian of Synovial Fibroblast Fate
Ellen M. Gravallese, Kevin Wei
2026-09-07 · DOI: 10.1002/art.70323A Coding Single Nucleotide Polymorphism in β2‐Glycoprotein I (APOH) is Associated with Increased Autoantibody Levels but Reduced Venous Thromboembolism Risk
Christophe Lalaurie, Lili Liu, Atlas Khan, Chen Wang et al.
2026-09-07 · DOI: 10.1002/art.70333CD248/Endosialin regulates synovial fibroblast state to control coupling of inflammation and bone damage in murine models of immune‐mediated inflammatory arthritis and ageing
Samuel Kemble, Corinna Wehmeyer, James M. Brown, Charlotte G. Smith et al.
2026-09-07 · DOI: 10.1002/art.70327FSCN1 Promotes Rheumatoid Arthritis Progression via Inhibiting TRIM38–Mediated Ubiquitination of IGF2BP1 in Fibroblast‐Like Synoviocytes
Liangyu Chen, Junfeng Wu, Tao Zhou, Zilin Zou et al.
2026-09-06 · DOI: 10.1002/art.70300DNMT3a loss in T cells attenuates experimental arthritis: implications for interpreting human clonal hematopoiesis of indeterminate potential–rheumatoid arthritis associations: comment on the article by Shen et al
Qiang Tong
2026-09-06 · DOI: 10.1002/art.70308Interleukin‐12 Signaling Promotes Podocyte Senescence in Lupus Nephritis
Chaohuan Guo, Rong Fu, Wenliang Pan, Wei Li et al.
2026-09-06 · DOI: 10.1002/art.70305CASTOR1 regulates humoral immune responses and contributes to the pathogenesis of systemic lupus erythematosus
Takeshi Kusuda, Toshihiko Komai, Takahiro Itamiya, Tatsuki Abe et al.
2026-09-04 · DOI: 10.1002/art.70314Early synovial regulatory T cell engagement in posttraumatic osteoarthritis
Xueyou Zhang, Mingde Cao, Jianting Li, Bruma Sai‐Chuen Fu et al.
2026-09-03 · DOI: 10.1002/art.70321Hepatotoxicity of Avacopan: Real‐World Incidence and Confirmed Cases of Severe Drug‐Induced Liver Injury in a US National Rheumatology Registry
Eric T. Roberts, Dina Dadabhoy, Ryan Antolini, Sharon A. Chung et al.
2026-09-01 · DOI: 10.1002/art.70304Reply
Yunbing Shen, Fredrik Wermeling
2026-09-01 · DOI: 10.1002/art.70309Reviews
Community Reviews
Version History
April 21, 2025 at 5:39 am
April 21, 2025